Delphia (USA)’s Tenet Healthcare THC Stock Holding History

Delphia (USA)’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,175	Closed	-$248K	–	300
2023 Q1	$248K	Buy	+4,175	New	+$232K	0.3%	156

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Delphia (USA)'s THC Position: Q2 2023 in Review

Delphia (USA) sold out of Tenet Healthcare (THC) in Q2 2023, closing a stake of 4,175 shares — an estimated $248K sold.

Delphia (USA) first reported a position in THC in Q1 2023 and held it in 1 quarter. The position peaked at $248K in Q1 2023. 416 funds tracked by Wall St. Rank hold THC as of Q2 2023.

Delphia (USA) reported no remaining Tenet Healthcare position as of Q2 2023 after selling out during the quarter.
Delphia (USA) sold 4,175 Tenet Healthcare shares in Q2 2023, an estimated $248K.
Delphia (USA) first reported a position in Tenet Healthcare in Q1 2023 and held it in 1 quarter.
Delphia (USA)'s Tenet Healthcare position peaked at $248K in Q1 2023.
416 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2023.

Based on Delphia (USA)'s 13F filing for Q2 2023, filed 14 Aug 2023.